Endocrine Treatment of Primary and Advanced Breast Cancer

Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia. A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. J Clin Oncol 1986; 4: 186–93.

Rose C. , Mouridsen H.T. Preferred sequence of endocrine therapies in advanced breast cancer. Endocrine dependent cancer: Critical assessment of recent advances. Ed. Richard Santen (in press).

Rose C. , Mouridsen H.T. , Thorpe S.M. , Andersen J. , Blichert-Toft M. , Andersen K.W. Anti-estrogen treatment of post-menopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status. World J Surgery 1985; 9: 765–74.

Wilson A.J. , Baum M. , Brinkley D.M. Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. World J Surgery 1985; 9: 756–64.